Results 21 to 30 of about 62,609,046 (216)
Torsades de Pointes Triggered by Transient Low‐Rate Pacing Following Leadless Pacemaker Implantation [PDF]
Yumetsugu Munakata +4 more
doaj +2 more sources
Ephedrine‐Triggered Torsades de Pointes in Two Patients Following Desflurane‐Induced QT Prolongation [PDF]
Shinichi Harada +4 more
doaj +2 more sources
Introduction: Idiopathic short-coupled ventricular tachyarrhythmias make up a considerable proportion of ventricular tachyarrhythmias in structurally normal hearts and are the cause of 5–10% of unexpected sudden cardiac deaths.
Mohammed Almehairi +2 more
doaj +1 more source
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database [PDF]
Background: Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden. Objective: As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US ...
MORETTI, Ugo +38 more
core +1 more source
Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes
There are several classes of medications that can cause prolongation of the corrected QT (QTc) interval and potentially Torsades de Pointes (TdP). Most of these medications are commonly used in the emergency department, and interaction between these ...
Karthik Gnanapandithan +2 more
doaj +1 more source
AbstractThe polymorphic ventricular tachycardia torsade de pointes can occur in the congenital long QT syndromes or as a consequence of therapy with QT‐prolonging drugs. The latter can include not only antiarrhythmic drugs such as quinidine, but also a number of drugs which are not usually considered to have major cardiovascular effects: these include ...
openaire +2 more sources
Ondansetron induced torsades de pointes
A single dose of oral Ondansetron can precipitate torsades de pointes and other arrhythmias in patients with risk factors that may prolong QTc interval.
Eshan Patel +2 more
doaj +1 more source
Case report: Ivabradine induced Torsades de Pointes
Ivabradine is used to control heart rate in patients of heart failure with reduced ejection fraction. Although considered safe, it is reported to prolong QTc interval when given with other QTc prolonging drugs or in setting of hypokalemia or ...
Mohit M. Bhagwati +2 more
doaj +1 more source
HALOPERIDOL-INDUCED TORSADES DE POINTES: A CASE REPORT
Torsades de pointes (Tdp) is a malignant polymorphic ventricular arrhythmia1 often associated with drugs like haloperidol that prolonged QTc interval2. If enough care is not taken this may lead to sudden death.
JAVED ATHER SIDDIQUI (8442636)
core +2 more sources
Pharmacological and therapeutical basis of torsades de pointes [PDF]
Torsades de pointes (TdP) is a specific form of polymorphic ventricular tachycardia, which is a dreadful condition, severity varies from mild asymptomatic condition to severe life threatening state.
Pakanati, Vijayakrishna +4 more
core +1 more source

